Ann MacLaren

Company: Triphase Accelerator
Job title: Executive Director, Translational Development
Seminars:
Highlighting the Phase 1 Pharmacokinetics & Safety Study of TRPH-222 in Patients with Relapsed/ Refractory B-cell Non-Hodgkin Lymphoma 12:00 pm
Summarise the SMARTag technology and Phase 1 study design Review of the safety and efficacy of TRPH-222 in R/R NHL Presenting our thoughts on future directions for ADCs using novel payload linkers and moving beyond cytotoxic payloadsRead more
day: Track C - Day 2